John P. Witkowski

TransEnterix is advancing the field of minimally invasive surgery through exploration, innovation and collaboration. Based in North Carolina's Research Triangle Park, TransEnterix is a rapidly growing medical device company founded in 2006. Since its inception the company has designed, received FDA approval and launched the groundbreaking SPIDER Surgical System, which provides surgeons with enhanced capabilities by creating triangulation via single site access with flexible articulating instruments. The platform enables a whole new class of less invasive surgery - Flexible Laparoscopy - which builds on the proven technologies of laparoscopic surgery and catheter based medical treatments.

Part of Stryker Corp., Stryker Orthopaedics Corp. is a company that specializes in orthopedic prosthetic and surgical appliances and supplies. The company is based in Manchester, NH.

MonoGen, Inc. is a medical device and diagnostics company. It provides cytological screening and diagnostic products to healthcare providers in the anatomic pathology industry. The company was founded on July 28, 1995 and is headquartered in Lincolnshire, IL.

Part of DSM-Firmenich AG, DSM Biomedical BV is a Dutch company that specializes in implantable drug delivery systems made of bioresorbable polymers. The private company is based in Geleen, the Netherlands. These systems release precise quantities of therapeutic agents gradually over time. DSM Biomedical materials and technologies are used in orthopedic applications, including spine, trauma, and sports medicine. White. The company was founded by Kathleen A.

The North Central Massachusetts Chamber of Commerce connects businesses in central Massachusetts. The non-profit company is based in Fitchburg, MA. The organization has been doing so for over 35 years. The CEO of the company is Roy Nascimento.

Solesis, Inc. is a life science and medical technology company that specializes in biomaterials for the life sciences industry. The company is based in Perkasie, PA, and has subsidiaries in the United States. The company operates through its subsidiaries, including The Secant Group LLC, Sanavita Medical LLC, and Charter Medical LLC. Solesis develops, manufactures, and sells critical components for implantable medical devices and single-use technologies for the biopharmaceutical market, including cell and gene therapies. Solesis was founded in 2011, and the CEO is Karen M. West. Solesis was acquired by Altaris Capital Partners LLC from Compagnie Générale des Établissements Michelin SCA on June 01, 2021 for $475 million.